5-Azacitidine in Low-risk Myelodysplastic Syndromes (MDSs)

NCT00897130 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
28
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Università degli Studi di Brescia

Collaborators